C.F.R.
»
Title 42
» CHAPTER IV—CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES › SUBCHAPTER B—MEDICARE PROGRAM › PART 405—FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED › Subpart B—Medical Services Coverage Decisions That Relate to Health Care Technology
(a) For any device that meets the requirements of the exception at § 411.15(o) of this chapter, the following procedures apply:
(1) The FDA notifies CMS, when it notifies the sponsor, that the device is categorized by FDA as Category B (Nonexperimental/investigational).
(2) CMS uses the categorization of the device as a factor in making Medicare coverage decisions.
(b) If the FDA becomes aware that a categorized device no longer meets the requirements of the exception at § 411.15(o) of this chapter, the FDA notifies the sponsor and CMS and the procedures described in paragraph (a)(2) of this section apply.
[60 FR 48423, Sept. 19, 1995, as amended at 78 FR 74809, Dec. 10, 2013
Notes of Decisions
Cited in
3
cases, 1982–2001 · leading case:
Plyler v. Doe, 457 U.S. 202 (1982).
Plyler v. Doe, 457 U.S. 202 (1982).
· cites it 2× “§ 1395i-2 and 42 CFR § 405.205 (b) (1981), and the Medicaid hospital insurance benefits for the aged and disabled program, 42 U.”
Yale-New Haven Hosp., Inc. v. Thompson, 162 F. Supp. 2d 54 (D. Conn. 2001).
“42 C.F.R. §§ 405.205 , 405.209, 405.211. Under the new regulations, the FDA assigns devices that have received IDE’s to one of two categories: Category A (experimental/investigational) or Category B (non-experimental/investigational) depending on whether initial questions as to…”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.